Altaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
Altaire Pharmaceuticals is recalling Equate Support Advanced Twin Pack eye drops due to a lack of assurance of sterility. The recall covers 259,104 units distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, an FDA Class II recall involving a significant hazard like lack of sterility (which implies potential for serious infection) is classified as Severe (Score 4), especially given the strict rule that Class I/II classifications with significant injury/property damage or high-risk pathogens/infections warrant higher severity. While no specific hospitalizations are listed in the snippet, 'Lack of Assurance of Sterility' for an ophthalmic product is a significant safety risk.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Equate Support Advanced Twin Pack (NDC 49035-885-49), a 2 x 15 mL package of eye drops. The recall is being conducted because of a lack of assurance of sterility in the product. The affected product is distributed by Wal-Mart Stores Inc. and was available nationwide in the United States.
The recall involves 259,104 units. The specific lot numbers and expiration dates affected are Lot 19137 (expiring 05/22) and Lot 19022 (expiring 01/22). Consumers should check their products for these specific lot numbers and expiration dates.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund. The FDA has classified this recall as Class II, which means there is a reasonable probability that the use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Equate Support Advanced Twin Pack W-M item #: 567371433, Package Size: 2 x 15 mL, Distributed by: Wal-Mart Stores Inc., Bentonville, AR 72716, NDC 49035-885-49
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 259,104
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 19137 05/22 19022 01/22
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Nano Tears Lubricant Gel Drops Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29